AA33418
Packsize | Purity | Availability | Price | Discounted Price | Quantity | |
---|---|---|---|---|---|---|
50mg | 95% | 1 week | $893.00 | $625.00 | - + | |
100mg | 95% | 1 week | $1,287.00 | $901.00 | - + | |
250mg | 95% | 1 week | $1,806.00 | $1,265.00 | - + | |
500mg | 95% | 1 week | $2,800.00 | $1,960.00 | - + | |
1g | 95% | 1 week | $3,566.00 | $2,496.00 | - + |
*All products are for research use only and not intended for human or animal use.
*All prices are in USD.
Catalog Number: | AA33418 |
Chemical Name: | 7-Fluoro-5-methoxy-2,3-dihydro-1H-inden-1-one |
CAS Number: | 1199782-74-5 |
Molecular Formula: | C10H9FO2 |
Molecular Weight: | 180.1757 |
MDL Number: | MFCD09908162 |
SMILES: | COc1cc(F)c2c(c1)CCC2=O |
Complexity: | 217 |
Covalently-Bonded Unit Count: | 1 |
Heavy Atom Count: | 13 |
Hydrogen Bond Acceptor Count: | 3 |
Rotatable Bond Count: | 1 |
XLogP3: | 1.7 |
7-Fluoro-5-methoxy-1-indanone is a versatile compound that finds wide application in chemical synthesis. It serves as a key building block in the preparation of various pharmaceuticals, agrochemicals, and fine chemicals due to its unique structural properties and reactivity. In chemical synthesis, 7-Fluoro-5-methoxy-1-indanone can be used as a precursor in the synthesis of novel heterocyclic compounds, which are important in drug discovery and development. Its fluorine atom imparts specific properties that can be exploited in medicinal chemistry, such as enhancing metabolic stability or improving binding affinity to biological targets.Additionally, the methoxy group on the indanone scaffold can serve as a directing group in organic reactions, enabling selective functionalization at specific positions on the molecule. This allows for the tailored modification of the compound to achieve desired properties or activities in the final product.Overall, the use of 7-Fluoro-5-methoxy-1-indanone in chemical synthesis offers chemists a valuable tool for designing and synthesizing new molecules with targeted properties, paving the way for the development of innovative pharmaceuticals and other high-value compounds.